Clinical trials in Leidschendam – page 42

1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leidschendam at a glance

1 919

clinical trials

Research sites1

Quick filters

1 919 trials in Leidschendam

Open in trial search

Rectal cancer

Recruiting

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Stichting Radboud University Medical Center

Contact Research Centre

Squamous cell carcinoma of lung+2

Recruiting

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:OSE Immunotherapeutics

Contact Research Centre

Obesity

Recruiting

Study of Semaglutide for Weight Loss in Obesity Patients with Low Response After Bariatric Surgery

InvestigationalNo placebo

Study of Semaglutide for Weight Loss in Obesity Patients with Low Response After Bariatric Surgery

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Zuyderland Medisch Centrum Stichting

Contact Research Centre

Endometrial cancer

Recruiting

Study of Pembrolizumab for Patients with Mismatch Repair Deficient Uterine Cancer

Registered drugNo placebo

Study of Pembrolizumab for Patients with Mismatch Repair Deficient Uterine Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Non-small cell lung cancer metastatic

Recruiting

Study on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors

InvestigationalNo placebo

Study on the Safety and Effects of STX-241 for Patients with Advanced Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:STX-241
Sponsor:Pierre Fabre Medicament

Contact Research Centre

Sedative therapy+1

Recruiting

A Study Comparing Remimazolam and Midazolam for Sedation in Adults During Upper Gastrointestinal Endoscopy

Registered drugNo placebo

A Study Comparing Remimazolam and Midazolam for Sedation in Adults During Upper Gastrointestinal Endoscopy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Midazolam
Sponsor:Sint Antonius Ziekenhuis Stichting

Contact Research Centre

Duchenne muscular dystrophy

Recruiting

Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

InvestigationalNo placebo

Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

InvestigationalNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Givinostat
Sponsor:Italfarmaco S.p.A.

Contact Research Centre

HER2 gene amplification

Recruiting

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Zongertinib
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Non-small cell lung cancer+4

Recruiting

Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

Registered drugNo placebo

Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:ETOP IBCSG Partners Foundation

Contact Research Centre

Giant cell arteritis

Recruiting

Study on [18F]Fluoro-PEG-Folate Imaging for Patients with Giant Cell Arteritis

InvestigationalNo placebo

Study on [18F]Fluoro-PEG-Folate Imaging for Patients with Giant Cell Arteritis

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Paroxysmal nocturnal haemoglobinuria

Recruiting

Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

Registered drugNo placebo

Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Pegcetacoplan
Sponsor:Apellis Pharmaceuticals Inc.

Contact Research Centre

Progressive multiple sclerosis

Recruiting

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational

The Netherlands

Participants:18–64 years
Substances:Vidofludimus Calcium
Sponsor:Immunic AG

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Leidschendam

What the registry says about research in the country

01 Oncology - Lung Cancer Research

Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

Advanced NSCLC treatments
Immunotherapy combinations
KRAS G12C inhibitors

Studies compare various treatment options to improve patient outcomes and survival rates.

02 Breast Cancer Studies

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.

Metastatic breast cancer
HER2-positive therapy
Triple-negative breast cancer

Trials examine innovative treatment strategies and personalized approaches.

03 Hematologic Malignancies

Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.

Advanced Hodgkin Lymphoma
Follicular Lymphoma
Treatment optimization

Research aims to improve treatment outcomes while minimizing toxicity.

04 Gastrointestinal Oncology

Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.

Rectal cancer treatments
Esophagogastric cancer
Surgical innovations

Focus on improving surgical outcomes and treatment effectiveness.

05 Brain Metastases Research

Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.

Radiation necrosis treatment
Metastatic detection
Targeted therapies

Research aims to improve detection and treatment of brain metastases.

Back to the Netherlands All countries